Nothing is more effective than the adoption of mature technological breakthrough for improving government efficiency at scale without pushback. BioinvestGPT could not only help DOGE cut $1 trillion healthcare-related spending, but also help DOGE add $1 trillion biopharma-related tax revenue. DOGE should focus on both cutting budgets and adding revenues. Check @DemiurgeTech for proof.
Demiurge AI-based #clinicaltrials outcome predictions made on February 05 2020 put to the public test (039_2020):
SUCCESS for
#rituximab / NCT03958890 / #Henlius
Demiurge AI-based #clinicaltrials outcome predictions made on February 05 2020 put to the public test (040_2020):
SUCCESS for
#Penpulimab / NCT03866993 / AK-105 / #AkesoBio@Fidelity
Demiurge AI-based #ataxia#clinicaltrials outcome predictions put to the public test (201_2020):
FAILURE for
#troriluzole / NCT03701399 / @BiohavenPharma $BHVN
Demiurge AI-based #keloid#clinicaltrials outcome predictions put to the public test (069_2020):
FAILURE for
#Remlarsen / NCT03601052 / @miRagenRx $MGEN